SCHEMBL7757955

SCHEMBL7757955

Cc1cc(C)cc(C[CH]c2ccccc2)c1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 9/20 0.39
TTR P02766 1/20 0.38
ALOX5 P09917 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
MAOB P27338 4/20 0.36
MAOA P21397 3/20 0.36
CYP19A1 P11511 2/20 0.36
CYP2A6 P11509 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3241749 0.81 LMNA (0.42) ALDH1A1HPGDMAOBMAOACYP2A6
SCHEMBL9509286 0.78 CYP2A6 (0.41) TTRALOX5PTGS1PTGS2ALDH1A1
SCHEMBL69726 0.77 MAOB (0.57) ALDH1A1HPGDMAOBMAOACYP2A6
SCHEMBL1987774 0.77 MAOB (0.46) ALDH1A1KDM4EHPGDMAOBCYP2A6
SCHEMBL8207446 0.76 TP53 (0.48) ALOX5PTGS1PTGS2ALDH1A1MAOB
SCHEMBL8097032 0.73 TP53 (0.50) ALOX5PTGS1PTGS2MAOBMAOA
SCHEMBL12500726 0.73 ALOX5 (0.59) TTRALOX5PTGS1PTGS2ALDH1A1
SCHEMBL12500728 0.73 ALOX5 (0.59) TTRALOX5PTGS1PTGS2ALDH1A1
Benzaldehyde SCHEMBL28085758 0.73 ALDH1A1 (0.70) ALOX5ALDH1A1MAOBMAOACYP2A6
SCHEMBL27969136 0.73 ALOX5 (0.59) TTRALOX5PTGS1PTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1073637-A1 3-(AMINO- OR AMINOALKYL)PYRIDINONE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF HIV RELATED DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2001-02-07 EP disclosed
WO-1999055676-A1 3-(AMINO- OR AMINOALKYL)PYRIDINONE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF HIV RELATED DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1999-11-04 WO disclosed